FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.

canSERV Open Call Education Webinar

Friday, 01. December 2023, 14:15 CET The canSERV team will introduce the project and its Access to 400+ cancer research tools and services Open Call for Transnational Service Provision Application […]

BBMRI.QM Newsroom

The fourth session in 2023 will be held on 5 December, 10:00-11:00 am CET via Zoom. We will welcome two guests:  - Mats Hansson (Senior Professor of Biomedical Ethics, Uppsala […]

BY-COVID Webinar: Using Containers as SPEs

Online

BY-COVID will hold a webinar on using containers as Secure Processing Environments to deploy federated research architectures reusing health data on: 📆 27 February 2024 | 15:00-16:45 CET | Online […]

Europe Biobank Week Congress 2024

The Hofburg Vienna, Austria

BBMRI-ERIC and ESBB are delighted to announce that the Europe Biobank Week Congress is back for 2024. It will take place from 14-17 May at The Hofburg in Vienna, Austria. […]

2nd QM Newsroom in 2024

Online

The second session in 2024 will be held on 28 May, 10:00-11:00 am CEST via Zoom on the topic of: Interoperability in biobanking: OMOP for standardising medical outcome data We […]

BioTechX Europe 2024

Messe Basel Messeplatz 10, Basel, Switzerland

BBMRI-ERIC will once again be at the BioTechX Europe Congress. Here’s why we would we delighted for you to join us: BioTechX Europe is Europe’s largest congress covering diagnostics, precision […]


The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept